
By Oluwapelumi Adejumo February 5th, 2021
According to a recent poll carried out by IBD/TIPP, more Americans are now willing to get vaccinated immediately when it becomes available to them.
Moderna specializes in drug discovery and drug development based on messenger RNA.
Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). The company creates synthetic mRNA that can be injected into patients to help them create their own therapies.
According to a recent poll carried out by IBD/TIPP, more Americans are now willing to get vaccinated immediately when it becomes available to them.
Sana raised a total of $587.5 million from its Initial Public Offering after ensuring that 23.5 million shares were released into the market.
In 2021, it is expected that Moderna will to generate $11 billion in revenue from its vaccine.